Watchlist Price Alert

CG Oncology Inc. Common s... (CGON)

NASDAQ: CGON · Real-Time Price · USD

25.41

-0.45 (-1.74%)

At close: Jun 16, 2025, 3:59 PM

25.46

0.20%

After-hours: Jun 16, 2025, 04:35 PM EDT

CG Oncology Common stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Revenue	662K	1.14M	684K	650K	539K	204K	203K	194K	194K	n/a
Cost of Revenue	7K	11K	15K	15K	12K	7.85M	7.85M	7.85M	7.85M	4K
Gross Profit	655K	1.13M	669K	635K	527K	-7.65M	-7.65M	-7.66M	-7.65M	-4K
Operating Income	-134.4M	-114.67M	-95.55M	-81.72M	-68.19M	-55.45M	-45.83M	-31.36M	-19.04M	-9.31M
Interest Income	28.83M	26.63M	20.38M	12.49M	6.32M	1.82M	1.82M	1.82M	1.05M	n/a
Pretax Income	-105.56M	-88.04M	-72.36M	-64.16M	-56.87M	-48.6M	-40.88M	-28.67M	-17.06M	-8.39M
Net Income	-105.56M	-88.04M	-72.36M	-64.16M	-56.87M	-48.6M	-40.88M	-28.67M	-17.06M	-8.39M
Selling & General & Admin	42.7M	33.7M	25.01M	18.61M	13.6M	9.89M	8.53M	6.22M	3.73M	1.65M
Research & Development	92.36M	82.1M	71.22M	63.76M	55.12M	45.75M	37.49M	25.33M	15.5M	7.66M
Other Expenses	n/a	-9K	-13K	-21K	-79K	-62K	-45K	-37K	21K	13K
Operating Expenses	135.06M	115.8M	96.22M	82.36M	68.72M	55.64M	46.02M	31.55M	19.23M	9.31M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	-4K	-8K	-8K	-12K	-8K	-8K	-8K	-4K	-4K
Cost & Expenses	135.06M	115.81M	96.23M	82.37M	68.73M	55.65M	46.03M	31.56M	19.23M	9.31M
Income Tax Expense	n/a	n/a	n/a	-2.27M	-2.27M	-3.31M	-3.31M	-1.05M	-1.05M	n/a
Shares Outstanding (Basic)	76.19M	64.82M	67.14M	66.65M	47.06M	66.64M	66.64M	66.64M	66.64M	66.64M
Shares Outstanding (Diluted)	76.19M	64.82M	67.14M	66.65M	47.06M	66.64M	66.64M	66.64M	66.64M	66.64M
EPS (Basic)	-1.52	-1.43	-1.18	-1.06	-0.95	-0.72	-0.61	-0.43	-0.26	-0.13
EPS (Diluted)	-1.52	-1.43	-1.18	-1.06	-0.95	-0.72	-0.61	-0.43	-0.26	-0.13
EBITDA	-134.36M	-114.64M	-95.52M	-81.71M	-68.18M	-55.43M	-45.81M	-31.35M	-19.03M	-9.31M
EBIT	-134.4M	-114.67M	-95.55M	-81.72M	-68.19M	-55.45M	-46.02M	-31.56M	-19.23M	-9.51M
Depreciation & Amortization	52K	32K	36K	20K	17K	17K	17K	12K	8K	4K